Global Oncology Resection Device Market Research Report 2026

Oncology Resection Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oncology Resection Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

An Oncology Resection Device refers to surgical instruments and energy platforms used to cut, dissect, separate, seal vessels for hemostasis, and retrieve tissue during removal of tumors or suspicious lesions. These devices support multiple approaches including open surgery, laparoscopy/thoracoscopy, endoscopy, and robot-assisted procedures. Product forms may include electrosurgical cutting and vessel-sealing instruments, ultrasonic devices, RF/microwave resection–ablation hybrids, endoscopic mucosal/submucosal resection tools, morcellation and tissue retrieval systems, often integrated with imaging/navigation, smoke evacuation, and irrigation–suction modules. The core value is enabling more precise tissue handling with less blood loss and fewer complications while maintaining oncologic principles and improving procedural efficiency and reproducibility.In 2025, global Oncology Resection Device production reached approximately 2.71 million Units and price is about 2000 USD/Unit.The average gross profit margin of this product is 55%.

Cancer care is accelerating toward earlier detection and minimally invasive intervention, expanding the pool of resectable cases and supporting sustained procedure volume. ERAS and faster recovery goals increase demand for efficient energy devices and single-use consumables that reduce operative time, bleeding, and length of stay. As complex oncologic surgeries evolve toward multidisciplinary and precision workflows, integrated solutions combining energy platforms, fine instruments, and visualization/navigation are increasingly favored by major hospitals, creating platform lock-in and recurring consumable demand. Safety and evidence requirements are high. Thermal injury control, smoke/aerosol management, handling of fragile vasculature and adhesions, and anatomical variability across specialties (HPB, thoracic, gynecology, urology, GI endoscopy, etc.) require highly stable energy output, temperature control, and mechanical reliability. Regulatory and hospital access decisions often weigh real-world complication profiles, learning curves, and cost-effectiveness. Under tendering and cost-containment pressures, commoditized products face price compression, pushing suppliers to defend differentiation through clinical value, training, and workflow support. Demand is shifting from single-instrument purchases to procedure-based standardized toolchains, prioritizing cut-and-seal integration, low thermal spread, fewer instrument exchanges, and compatibility with endoscopic, laparoscopic, and robotic interfaces. For early cancers, growth in endoscopic submucosal dissection and local resection drives upgrades in precision knives, injection needles, traction, and retrieval systems. For complex solid tumors, emphasis rises on reliable hemostasis, smoke control, and intraoperative navigation synergy. Single-use traceable consumables and workflow solutions linking pre-op planning to pathology integration are emerging competitive priorities. Upstream inputs include medical metals and polymers plus energy/control components. Blades and jaws commonly use stainless steel, titanium alloys, and hard coatings; insulation and handles rely on high-performance polymers. Energy platforms require generators, cables, sensors, and control chips, alongside sterile single-use packaging and precision molding for disposables. For electrosurgical/ultrasonic/RF devices, heat resistance, electrical insulation integrity, and surface-finish consistency directly shape safety margins and user experience. Supply-chain advantage depends on precision machining and assembly yield, sterilization compatibility, stable sourcing of key electronics, and consistent quality at scale with cost discipline.

This report delivers a comprehensive overview of the global Oncology Resection Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncology Resection Device. The Oncology Resection Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oncology Resection Device market comprehensively. Regional market sizes by Type, by Application, by Surgical Approach, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oncology Resection Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Oncology Resection Device Market Report

Chapter Outline

1.1 Product Definition

1.2 Oncology Resection Device by Type

1.2.1 Global Oncology Resection Device Market Value by Type: 2025 vs 2032

1.2.2 Electrosurgical Devices

1.2.3 Ultrasonic Devices

1.2.4 Laser Resection

1.3 Oncology Resection Device by Surgical Approach

1.3.1 Global Oncology Resection Device Market Value by Surgical Approach: 2025 vs 2032

1.3.2 Open Surgery

1.3.3 Laparoscopic/Thoracoscopic

1.3.4 Endoscopic

1.4 Oncology Resection Device by Cnacer Type

1.4.1 Global Oncology Resection Device Market Value by Cnacer Type: 2025 vs 2032

1.4.2 Solid Tumors

1.4.3 Hematologic

1.5 Oncology Resection Device by Application

1.5.1 Global Oncology Resection Device Market Value by Application: 2025 vs 2032

1.5.2 Hospitals

1.5.3 Cancer Centers

1.5.4 Other

1.6 Global Oncology Resection Device Market Size Estimates and Forecasts

1.6.1 Global Oncology Resection Device Revenue 2021–2032

1.6.2 Global Oncology Resection Device Sales 2021–2032

1.6.3 Global Oncology Resection Device Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2.1 Global Oncology Resection Device Sales Market Share by Manufacturers (2021–2026)

2.2 Global Oncology Resection Device Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Oncology Resection Device Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Oncology Resection Device, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Oncology Resection Device, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Oncology Resection Device, Product Types and Applications

2.7 Global Key Manufacturers of Oncology Resection Device, Date of Entry into the Industry

2.8 Global Oncology Resection Device Market Competitive Situation and Trends

2.8.1 Global Oncology Resection Device Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Oncology Resection Device Players Market Share by Revenue

2.8.3 Global Oncology Resection Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Oncology Resection Device Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Oncology Resection Device Sales by Region: 2021–2032

3.2.1 Global Oncology Resection Device Sales by Region: 2021–2026

3.2.2 Global Oncology Resection Device Sales by Region: 2027–2032

3.3 Global Oncology Resection Device Revenue by Region: 2021–2032

3.3.1 Global Oncology Resection Device Revenue by Region: 2021–2026

3.3.2 Global Oncology Resection Device Revenue by Region: 2027–2032

3.4 North America Oncology Resection Device Market Facts & Figures by Country

3.4.1 North America Oncology Resection Device Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Oncology Resection Device Sales by Country (2021–2032)

3.4.3 North America Oncology Resection Device Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oncology Resection Device Market Facts & Figures by Country

3.5.1 Europe Oncology Resection Device Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Oncology Resection Device Sales by Country (2021–2032)

3.5.3 Europe Oncology Resection Device Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oncology Resection Device Market Facts & Figures by Region

3.6.1 Asia Pacific Oncology Resection Device Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Oncology Resection Device Sales by Region (2021–2032)

3.6.3 Asia Pacific Oncology Resection Device Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Oncology Resection Device Market Facts & Figures by Country

3.7.1 Latin America Oncology Resection Device Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Oncology Resection Device Sales by Country (2021–2032)

3.7.3 Latin America Oncology Resection Device Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Oncology Resection Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Oncology Resection Device Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Oncology Resection Device Sales by Country (2021–2032)

3.8.3 Middle East and Africa Oncology Resection Device Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Oncology Resection Device Sales by Type (2021–2032)

4.1.1 Global Oncology Resection Device Sales by Type (2021–2026)

4.1.2 Global Oncology Resection Device Sales by Type (2027–2032)

4.1.3 Global Oncology Resection Device Sales Market Share by Type (2021–2032)

4.2 Global Oncology Resection Device Revenue by Type (2021–2032)

4.2.1 Global Oncology Resection Device Revenue by Type (2021–2026)

4.2.2 Global Oncology Resection Device Revenue by Type (2027–2032)

4.2.3 Global Oncology Resection Device Revenue Market Share by Type (2021–2032)

4.3 Global Oncology Resection Device Price by Type (2021–2032)

5.1 Global Oncology Resection Device Sales by Application (2021–2032)

5.1.1 Global Oncology Resection Device Sales by Application (2021–2026)

5.1.2 Global Oncology Resection Device Sales by Application (2027–2032)

5.1.3 Global Oncology Resection Device Sales Market Share by Application (2021–2032)

5.2 Global Oncology Resection Device Revenue by Application (2021–2032)

5.2.1 Global Oncology Resection Device Revenue by Application (2021–2026)

5.2.2 Global Oncology Resection Device Revenue by Application (2027–2032)

5.2.3 Global Oncology Resection Device Revenue Market Share by Application (2021–2032)

5.3 Global Oncology Resection Device Price by Application (2021–2032)

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Medtronic Oncology Resection Device Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 J &J

6.2.1 J &J Company Information

6.2.2 J &J Description and Business Overview

6.2.3 J &J Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 J &J Oncology Resection Device Product Portfolio

6.2.5 J &J Recent Developments/Updates

6.3 B. Braun (Aesculap)

6.3.1 B. Braun (Aesculap) Company Information

6.3.2 B. Braun (Aesculap) Description and Business Overview

6.3.3 B. Braun (Aesculap) Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 B. Braun (Aesculap) Oncology Resection Device Product Portfolio

6.3.5 B. Braun (Aesculap) Recent Developments/Updates

6.4 ConMed

6.4.1 ConMed Company Information

6.4.2 ConMed Description and Business Overview

6.4.3 ConMed Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 ConMed Oncology Resection Device Product Portfolio

6.4.5 ConMed Recent Developments/Updates

6.5 Olympus

6.5.1 Olympus Company Information

6.5.2 Olympus Description and Business Overview

6.5.3 Olympus Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Olympus Oncology Resection Device Product Portfolio

6.5.5 Olympus Recent Developments/Updates

6.6 ERBE

6.6.1 ERBE Company Information

6.6.2 ERBE Description and Business Overview

6.6.3 ERBE Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 ERBE Oncology Resection Device Product Portfolio

6.6.5 ERBE Recent Developments/Updates

6.7 LED SPA

6.7.1 LED SPA Company Information

6.7.2 LED SPA Description and Business Overview

6.7.3 LED SPA Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 LED SPA Oncology Resection Device Product Portfolio

6.7.5 LED SPA Recent Developments/Updates

6.8 Cooper Surgical

6.8.1 Cooper Surgical Company Information

6.8.2 Cooper Surgical Description and Business Overview

6.8.3 Cooper Surgical Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Cooper Surgical Oncology Resection Device Product Portfolio

6.8.5 Cooper Surgical Recent Developments/Updates

6.9 Karl Storz

6.9.1 Karl Storz Company Information

6.9.2 Karl Storz Description and Business Overview

6.9.3 Karl Storz Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Karl Storz Oncology Resection Device Product Portfolio

6.9.5 Karl Storz Recent Developments/Updates

6.10 KLS Martin

6.10.1 KLS Martin Company Information

6.10.2 KLS Martin Description and Business Overview

6.10.3 KLS Martin Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 KLS Martin Oncology Resection Device Product Portfolio

6.10.5 KLS Martin Recent Developments/Updates

6.11 Soering

6.11.1 Soering Company Information

6.11.2 Soering Description and Business Overview

6.11.3 Soering Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Soering Oncology Resection Device Product Portfolio

6.11.5 Soering Recent Developments/Updates

6.12 Utah Medical

6.12.1 Utah Medical Company Information

6.12.2 Utah Medical Description and Business Overview

6.12.3 Utah Medical Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Utah Medical Oncology Resection Device Product Portfolio

6.12.5 Utah Medical Recent Developments/Updates

6.13 Symmetry Surgical (Bovie)

6.13.1 Symmetry Surgical (Bovie) Company Information

6.13.2 Symmetry Surgical (Bovie) Description and Business Overview

6.13.3 Symmetry Surgical (Bovie) Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Symmetry Surgical (Bovie) Oncology Resection Device Product Portfolio

6.13.5 Symmetry Surgical (Bovie) Recent Developments/Updates

6.14 Eschmann

6.14.1 Eschmann Company Information

6.14.2 Eschmann Description and Business Overview

6.14.3 Eschmann Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Eschmann Oncology Resection Device Product Portfolio

6.14.5 Eschmann Recent Developments/Updates

6.15 Meyer-Haake

6.15.1 Meyer-Haake Company Information

6.15.2 Meyer-Haake Description and Business Overview

6.15.3 Meyer-Haake Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Meyer-Haake Oncology Resection Device Product Portfolio

6.15.5 Meyer-Haake Recent Developments/Updates

6.16 Ellman

6.16.1 Ellman Company Information

6.16.2 Ellman Description and Business Overview

6.16.3 Ellman Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Ellman Oncology Resection Device Product Portfolio

6.16.5 Ellman Recent Developments/Updates

6.17 IBBAB

6.17.1 IBBAB Company Information

6.17.2 IBBAB Description and Business Overview

6.17.3 IBBAB Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 IBBAB Oncology Resection Device Product Portfolio

6.17.5 IBBAB Recent Developments/Updates

6.18 Lamidey

6.18.1 Lamidey Company Information

6.18.2 Lamidey Description and Business Overview

6.18.3 Lamidey Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Lamidey Oncology Resection Device Product Portfolio

6.18.5 Lamidey Recent Developments/Updates

6.19 Bowa

6.19.1 Bowa Company Information

6.19.2 Bowa Description and Business Overview

6.19.3 Bowa Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.19.4 Bowa Oncology Resection Device Product Portfolio

6.19.5 Bowa Recent Developments/Updates

6.20 Union Medical

6.20.1 Union Medical Company Information

6.20.2 Union Medical Description and Business Overview

6.20.3 Union Medical Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.20.4 Union Medical Oncology Resection Device Product Portfolio

6.20.5 Union Medical Recent Developments/Updates

6.21 Shanghai Hutong

6.21.1 Shanghai Hutong Company Information

6.21.2 Shanghai Hutong Description and Business Overview

6.21.3 Shanghai Hutong Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.21.4 Shanghai Hutong Oncology Resection Device Product Portfolio

6.21.5 Shanghai Hutong Recent Developments/Updates

6.22 KINDY ELECTRONIC

6.22.1 KINDY ELECTRONIC Company Information

6.22.2 KINDY ELECTRONIC Description and Business Overview

6.22.3 KINDY ELECTRONIC Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.22.4 KINDY ELECTRONIC Oncology Resection Device Product Portfolio

6.22.5 KINDY ELECTRONIC Recent Developments/Updates

6.23 Heal Force

6.23.1 Heal Force Company Information

6.23.2 Heal Force Description and Business Overview

6.23.3 Heal Force Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.23.4 Heal Force Oncology Resection Device Product Portfolio

6.23.5 Heal Force Recent Developments/Updates

6.24 Changzhou Yanling

6.24.1 Changzhou Yanling Company Information

6.24.2 Changzhou Yanling Description and Business Overview

6.24.3 Changzhou Yanling Oncology Resection Device Sales, Revenue, and Gross Margin (2021–2026)

6.24.4 Changzhou Yanling Oncology Resection Device Product Portfolio

6.24.5 Changzhou Yanling Recent Developments/Updates

7.1 Oncology Resection Device Industry Chain Analysis

7.2 Oncology Resection Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oncology Resection Device Production Mode & Process Analysis

7.4 Oncology Resection Device Sales and Marketing

7.4.1 Oncology Resection Device Sales Channels

7.4.2 Oncology Resection Device Distributors

7.5 Oncology Resection Device Customer Analysis

8.1 Oncology Resection Device Industry Trends

8.2 Oncology Resection Device Market Drivers

8.3 Oncology Resection Device Market Challenges

8.4 Oncology Resection Device Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Oncology Resection Device Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Oncology Resection Device Market Value by Surgical Approach (US$ Million), 2025 vs 2032

 Table 3. Global Oncology Resection Device Market Value by Cnacer Type (US$ Million), 2025 vs 2032

 Table 4. Global Oncology Resection Device Market Value by Application (US$ Million), 2025 vs 2032

 Table 5. Global Oncology Resection Device Market Competitive Situation by Manufacturers in 2025

 Table 6. Global Oncology Resection Device Sales (Units) of Key Manufacturers (2021–2026)

 Table 7. Global Oncology Resection Device Sales Market Share by Manufacturers (2021–2026)

 Table 8. Global Oncology Resection Device Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 9. Global Oncology Resection Device Revenue Share by Manufacturers (2021–2026)

 Table 10. Global Market Oncology Resection Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)

 Table 11. Global Key Players of Oncology Resection Device, Industry Ranking, 2023 vs 2024 vs 2025

 Table 12. Global Key Manufacturers of Oncology Resection Device, Manufacturing Sites and Headquarters

 Table 13. Global Key Manufacturers of Oncology Resection Device, Product Types and Applications

 Table 14. Global Key Manufacturers of Oncology Resection Device, Date of Entry into the Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Oncology Resection Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oncology Resection Device Revenue, 2025

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Oncology Resection Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 19. Global Oncology Resection Device Sales by Region (Units), 2021–2026

 Table 20. Global Oncology Resection Device Sales Market Share by Region (2021–2026)

 Table 21. Global Oncology Resection Device Sales by Region (Units), 2027–2032

 Table 22. Global Oncology Resection Device Sales Market Share by Region (2027–2032)

 Table 23. Global Oncology Resection Device Revenue by Region (US$ Million), 2021–2026

 Table 24. Global Oncology Resection Device Revenue Market Share by Region (2021–2026)

 Table 25. Global Oncology Resection Device Revenue by Region (US$ Million), 2027–2032

 Table 26. Global Oncology Resection Device Revenue Market Share by Region (2027–2032)

 Table 27. North America Oncology Resection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 28. North America Oncology Resection Device Sales by Country (Units), 2021–2026

 Table 29. North America Oncology Resection Device Sales by Country (Units), 2027–2032

 Table 30. North America Oncology Resection Device Revenue by Country (US$ Million), 2021–2026

 Table 31. North America Oncology Resection Device Revenue by Country (US$ Million), 2027–2032

 Table 32. Europe Oncology Resection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 33. Europe Oncology Resection Device Sales by Country (Units), 2021–2026

 Table 34. Europe Oncology Resection Device Sales by Country (Units), 2027–2032

 Table 35. Europe Oncology Resection Device Revenue by Country (US$ Million), 2021–2026

 Table 36. Europe Oncology Resection Device Revenue by Country (US$ Million), 2027–2032

 Table 37. Asia Pacific Oncology Resection Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 38. Asia Pacific Oncology Resection Device Sales by Region (Units), 2021–2026

 Table 39. Asia Pacific Oncology Resection Device Sales by Region (Units), 2027–2032

 Table 40. Asia Pacific Oncology Resection Device Revenue by Region (US$ Million), 2021–2026

 Table 41. Asia Pacific Oncology Resection Device Revenue by Region (US$ Million), 2027–2032

 Table 42. Latin America Oncology Resection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 43. Latin America Oncology Resection Device Sales by Country (Units), 2021–2026

 Table 44. Latin America Oncology Resection Device Sales by Country (Units), 2027–2032

 Table 45. Latin America Oncology Resection Device Revenue by Country (US$ Million), 2021–2026

 Table 46. Latin America Oncology Resection Device Revenue by Country (US$ Million), 2027–2032

 Table 47. Middle East and Africa Oncology Resection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 48. Middle East and Africa Oncology Resection Device Sales by Country (Units), 2021–2026

 Table 49. Middle East and Africa Oncology Resection Device Sales by Country (Units), 2027–2032

 Table 50. Middle East and Africa Oncology Resection Device Revenue by Country (US$ Million), 2021–2026

 Table 51. Middle East and Africa Oncology Resection Device Revenue by Country (US$ Million), 2027–2032

 Table 52. Global Oncology Resection Device Sales (Units) by Type (2021–2026)

 Table 53. Global Oncology Resection Device Sales (Units) by Type (2027–2032)

 Table 54. Global Oncology Resection Device Sales Market Share by Type (2021–2026)

 Table 55. Global Oncology Resection Device Sales Market Share by Type (2027–2032)

 Table 56. Global Oncology Resection Device Revenue (US$ Million) by Type (2021–2026)

 Table 57. Global Oncology Resection Device Revenue (US$ Million) by Type (2027–2032)

 Table 58. Global Oncology Resection Device Revenue Market Share by Type (2021–2026)

 Table 59. Global Oncology Resection Device Revenue Market Share by Type (2027–2032)

 Table 60. Global Oncology Resection Device Price (US$/Unit) by Type (2021–2026)

 Table 61. Global Oncology Resection Device Price (US$/Unit) by Type (2027–2032)

 Table 62. Global Oncology Resection Device Sales (Units) by Application (2021–2026)

 Table 63. Global Oncology Resection Device Sales (Units) by Application (2027–2032)

 Table 64. Global Oncology Resection Device Sales Market Share by Application (2021–2026)

 Table 65. Global Oncology Resection Device Sales Market Share by Application (2027–2032)

 Table 66. Global Oncology Resection Device Revenue (US$ Million) by Application (2021–2026)

 Table 67. Global Oncology Resection Device Revenue (US$ Million) by Application (2027–2032)

 Table 68. Global Oncology Resection Device Revenue Market Share by Application (2021–2026)

 Table 69. Global Oncology Resection Device Revenue Market Share by Application (2027–2032)

 Table 70. Global Oncology Resection Device Price (US$/Unit) by Application (2021–2026)

 Table 71. Global Oncology Resection Device Price (US$/Unit) by Application (2027–2032)

 Table 72. Medtronic Company Information

 Table 73. Medtronic Description and Business Overview

 Table 74. Medtronic Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 75. Medtronic Oncology Resection Device Product

 Table 76. Medtronic Recent Developments/Updates

 Table 77. J &J Company Information

 Table 78. J &J Description and Business Overview

 Table 79. J &J Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 80. J &J Oncology Resection Device Product

 Table 81. J &J Recent Developments/Updates

 Table 82. B. Braun (Aesculap) Company Information

 Table 83. B. Braun (Aesculap) Description and Business Overview

 Table 84. B. Braun (Aesculap) Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 85. B. Braun (Aesculap) Oncology Resection Device Product

 Table 86. B. Braun (Aesculap) Recent Developments/Updates

 Table 87. ConMed Company Information

 Table 88. ConMed Description and Business Overview

 Table 89. ConMed Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 90. ConMed Oncology Resection Device Product

 Table 91. ConMed Recent Developments/Updates

 Table 92. Olympus Company Information

 Table 93. Olympus Description and Business Overview

 Table 94. Olympus Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 95. Olympus Oncology Resection Device Product

 Table 96. Olympus Recent Developments/Updates

 Table 97. ERBE Company Information

 Table 98. ERBE Description and Business Overview

 Table 99. ERBE Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 100. ERBE Oncology Resection Device Product

 Table 101. ERBE Recent Developments/Updates

 Table 102. LED SPA Company Information

 Table 103. LED SPA Description and Business Overview

 Table 104. LED SPA Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 105. LED SPA Oncology Resection Device Product

 Table 106. LED SPA Recent Developments/Updates

 Table 107. Cooper Surgical Company Information

 Table 108. Cooper Surgical Description and Business Overview

 Table 109. Cooper Surgical Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 110. Cooper Surgical Oncology Resection Device Product

 Table 111. Cooper Surgical Recent Developments/Updates

 Table 112. Karl Storz Company Information

 Table 113. Karl Storz Description and Business Overview

 Table 114. Karl Storz Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 115. Karl Storz Oncology Resection Device Product

 Table 116. Karl Storz Recent Developments/Updates

 Table 117. KLS Martin Company Information

 Table 118. KLS Martin Description and Business Overview

 Table 119. KLS Martin Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 120. KLS Martin Oncology Resection Device Product

 Table 121. KLS Martin Recent Developments/Updates

 Table 122. Soering Company Information

 Table 123. Soering Description and Business Overview

 Table 124. Soering Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 125. Soering Oncology Resection Device Product

 Table 126. Soering Recent Developments/Updates

 Table 127. Utah Medical Company Information

 Table 128. Utah Medical Description and Business Overview

 Table 129. Utah Medical Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 130. Utah Medical Oncology Resection Device Product

 Table 131. Utah Medical Recent Developments/Updates

 Table 132. Symmetry Surgical (Bovie) Company Information

 Table 133. Symmetry Surgical (Bovie) Description and Business Overview

 Table 134. Symmetry Surgical (Bovie) Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 135. Symmetry Surgical (Bovie) Oncology Resection Device Product

 Table 136. Symmetry Surgical (Bovie) Recent Developments/Updates

 Table 137. Eschmann Company Information

 Table 138. Eschmann Description and Business Overview

 Table 139. Eschmann Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 140. Eschmann Oncology Resection Device Product

 Table 141. Eschmann Recent Developments/Updates

 Table 142. Meyer-Haake Company Information

 Table 143. Meyer-Haake Description and Business Overview

 Table 144. Meyer-Haake Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 145. Meyer-Haake Oncology Resection Device Product

 Table 146. Meyer-Haake Recent Developments/Updates

 Table 147. Ellman Company Information

 Table 148. Ellman Description and Business Overview

 Table 149. Ellman Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 150. Ellman Oncology Resection Device Product

 Table 151. Ellman Recent Developments/Updates

 Table 152. IBBAB Company Information

 Table 153. IBBAB Description and Business Overview

 Table 154. IBBAB Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 155. IBBAB Oncology Resection Device Product

 Table 156. IBBAB Recent Developments/Updates

 Table 157. Lamidey Company Information

 Table 158. Lamidey Description and Business Overview

 Table 159. Lamidey Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 160. Lamidey Oncology Resection Device Product

 Table 161. Lamidey Recent Developments/Updates

 Table 162. Bowa Company Information

 Table 163. Bowa Description and Business Overview

 Table 164. Bowa Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 165. Bowa Oncology Resection Device Product

 Table 166. Bowa Recent Developments/Updates

 Table 167. Union Medical Company Information

 Table 168. Union Medical Description and Business Overview

 Table 169. Union Medical Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 170. Union Medical Oncology Resection Device Product

 Table 171. Union Medical Recent Developments/Updates

 Table 172. Shanghai Hutong Company Information

 Table 173. Shanghai Hutong Description and Business Overview

 Table 174. Shanghai Hutong Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 175. Shanghai Hutong Oncology Resection Device Product

 Table 176. Shanghai Hutong Recent Developments/Updates

 Table 177. KINDY ELECTRONIC Company Information

 Table 178. KINDY ELECTRONIC Description and Business Overview

 Table 179. KINDY ELECTRONIC Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 180. KINDY ELECTRONIC Oncology Resection Device Product

 Table 181. KINDY ELECTRONIC Recent Developments/Updates

 Table 182. Heal Force Company Information

 Table 183. Heal Force Description and Business Overview

 Table 184. Heal Force Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 185. Heal Force Oncology Resection Device Product

 Table 186. Heal Force Recent Developments/Updates

 Table 187. Changzhou Yanling Company Information

 Table 188. Changzhou Yanling Description and Business Overview

 Table 189. Changzhou Yanling Oncology Resection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 190. Changzhou Yanling Oncology Resection Device Product

 Table 191. Changzhou Yanling Recent Developments/Updates

 Table 192. Key Raw Materials Lists

 Table 193. Raw Materials Key Suppliers Lists

 Table 194. Oncology Resection Device Distributors List

 Table 195. Oncology Resection Device Customers List

 Table 196. Oncology Resection Device Market Trends

 Table 197. Oncology Resection Device Market Drivers

 Table 198. Oncology Resection Device Market Challenges

 Table 199. Oncology Resection Device Market Restraints

 Table 200. Research Programs/Design for This Report

 Table 201. Key Data Information from Secondary Sources

 Table 202. Key Data Information from Primary Sources

 Table 203. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Oncology Resection Device

 Figure 2. Global Oncology Resection Device Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Oncology Resection Device Market Share by Type: 2025 & 2032

 Figure 4. Electrosurgical Devices Product Picture

 Figure 5. Ultrasonic Devices Product Picture

 Figure 6. Laser Resection Product Picture

 Figure 7. Global Oncology Resection Device Market Value by Surgical Approach (US$ Million), 2021–2032

 Figure 8. Global Oncology Resection Device Market Share by Surgical Approach: 2025 vs 2032

 Figure 9. Open Surgery Product Picture

 Figure 10. Laparoscopic/Thoracoscopic Product Picture

 Figure 11. Endoscopic Product Picture

 Figure 12. Global Oncology Resection Device Market Value by Cnacer Type (US$ Million), 2021–2032

 Figure 13. Global Oncology Resection Device Market Share by Cnacer Type: 2025 vs 2032

 Figure 14. Solid Tumors Product Picture

 Figure 15. Hematologic Product Picture

 Figure 16. Global Oncology Resection Device Market Value by Application (US$ Million), 2021–2032

 Figure 17. Global Oncology Resection Device Market Share by Application: 2025 & 2032

 Figure 18. Hospitals

 Figure 19. Cancer Centers

 Figure 20. Other

 Figure 21. Global Oncology Resection Device Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 22. Global Oncology Resection Device Market Size (US$ Million), 2021–2032

 Figure 23. Global Oncology Resection Device Sales (Units), 2021–2032

 Figure 24. Global Oncology Resection Device Average Price (US$/Unit), 2021–2032

 Figure 25. Oncology Resection Device Report Years Considered

 Figure 26. Oncology Resection Device Sales Share by Manufacturers in 2025

 Figure 27. Global Oncology Resection Device Revenue Share by Manufacturers in 2025

 Figure 28. Top 5 and Top 10 Global Oncology Resection Device Players: Market Share by Revenue in Oncology Resection Device in 2025

 Figure 29. Oncology Resection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 30. Global Oncology Resection Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 31. North America Oncology Resection Device Sales Market Share by Country (2021–2032)

 Figure 32. North America Oncology Resection Device Revenue Market Share by Country (2021–2032)

 Figure 33. United States Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 34. Canada Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 35. Europe Oncology Resection Device Sales Market Share by Country (2021–2032)

 Figure 36. Europe Oncology Resection Device Revenue Market Share by Country (2021–2032)

 Figure 37. Germany Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. France Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 39. U.K. Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Italy Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Russia Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 42. Asia Pacific Oncology Resection Device Sales Market Share by Region (2021–2032)

 Figure 43. Asia Pacific Oncology Resection Device Revenue Market Share by Region (2021–2032)

 Figure 44. China Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 45. Japan Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. South Korea Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. India Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. Australia Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 49. China Taiwan Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 50. Southeast Asia Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 51. Latin America Oncology Resection Device Sales Market Share by Country (2021–2032)

 Figure 52. Latin America Oncology Resection Device Revenue Market Share by Country (2021–2032)

 Figure 53. Mexico Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 54. Brazil Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 55. Argentina Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Colombia Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 57. Middle East and Africa Oncology Resection Device Sales Market Share by Country (2021–2032)

 Figure 58. Middle East and Africa Oncology Resection Device Revenue Market Share by Country (2021–2032)

 Figure 59. Turkey Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 60. Saudi Arabia Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 61. UAE Oncology Resection Device Revenue Growth Rate (US$ Million), 2021–2032

 Figure 62. Global Sales Market Share of Oncology Resection Device by Type (2021–2032)

 Figure 63. Global Revenue Market Share of Oncology Resection Device by Type (2021–2032)

 Figure 64. Global Oncology Resection Device Price (US$/Unit) by Type (2021–2032)

 Figure 65. Global Sales Market Share of Oncology Resection Device by Application (2021–2032)

 Figure 66. Global Revenue Market Share of Oncology Resection Device by Application (2021–2032)

 Figure 67. Global Oncology Resection Device Price (US$/Unit) by Application (2021–2032)

 Figure 68. Oncology Resection Device Value Chain

 Figure 69. Channels of Distribution (Direct Vs Distribution)

 Figure 70. Bottom-up and Top-down Approaches for This Report

 Figure 71. Data Triangulation

 Figure 72. Key Executives Interviewed